THE WOODLANDS, Texas, Jan. 6 -- Community oncologists, practice administrators and clinical staff interested in learning
To encourage adoption of Electronic Health Records (EHR) systems, ARRA offers physicians the potential to earn up to $44,000 in incentives over a five-year period when they demonstrate meaningful use of certified EHRs. In this webinar, Peter Harrison, M.D., manager of physician products at iKnowMed™, an oncology-specific EHR supported by US Oncology, Inc., joins Matt Brow, vice president of Corporate Communications & Government Relations for US Oncology, and Cindy Chavez, vice president of iKnowMed™ to discuss recent updates regarding the rules for meaningful use, EHR certification requirements, and their effect on Medicare Health Information Technology (HIT) incentives. Based on their collective years of experience in the community-based oncology industry, the speakers will offer their perspective on how these standards should be set and applied to oncology practices.
Dr. Harrison hosts a bi-weekly meeting of oncology EHR vendors to discuss common certification issues among its members including people from US Oncology's iKnowMed™, Varian's ARIA, Elekta/Impac's MOSAIQ, and Altos' OncoEMR. He also attends the HIT Policy Committee and HIT Standards Committee meetings, as well as the calls for the Certification Commission for Health Information Technology (CCHIT). Dr. Harrison is an active member in the HL7 EHR System Functional Model work group, currently defining version 2.0 requirements and compliance criteria, and of the workgroup defining the HL7 EHR-S FM profile for stand-alone electronic prescribing.
US Oncology offers free webinars through its Oncology Practice Education Series designed to provide community-based oncology practices with information and education to help them successfully negotiate today's cancer care environment. The company is well aligned with more than 1,300 oncologists from across the nation and is active in all relevant health care initiatives and in pursuing legislation that supports the delivery of quality cancer care in the community. US Oncology is dedicated to providing the industry with timely and important information about current legislation changes that will impact its network and community-based oncology overall.
About US Oncology
US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology uses its expertise to support every aspect of the cancer care delivery system -- from drug development to distribution and outcomes measurement -- enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.
SOURCE US Oncology, Inc.
Subscribe to our Free Newsletters!
Statins are a group of drugs which help to lower the blood cholesterol levels.
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids ...